Date: Monday, Sept. 23rd
Time: 7:00 PM
Location: McGill University, Leacock Building - Rm 132 (attached to the McGill Arts Building) - 855 Sherbrooke St W, Montreal, Quebec H3A 2T7
The Leacock Building is attached to the Arts Building, which, when looking through the Roddick Gates from Sherbrooke Street, is directly in front of you. The Leacock building is attached to Arts, right on the left side of the building.
The Leacock Building can be accessed via the Roddick Gates on Sherbrooke, the gate on McTavish, or through the Milton Gates (University and Milton).
This event is in-person only and not live-streamed.
It will be recorded and made available for viewing afterward on our YouTube channel. Please subscribe to our channel to receive a notification.
Our Speakers
Dr. Patricia Brubaker | "The Basic Science Underlying the Beneficial Actions of Ozempic"
Dr. Brubaker will describe the fundamental studies undertaken by academic researchers that enabled the development of the intestinal hormone, glucagon-like peptide-1, as a novel therapeutic for the treatment of patients with type 2 diabetes and obesity.
Dr. Patricia Brubaker obtained her BSc and Ph.D. at McGill University followed by post-doctoral studies and then a faculty appointment at the University of Toronto. She is currently Professor Emerita in the Departments of Physiology and Medicine. At the University of Toronto, her research career focussed on the fundamental biology of the intestinal hormones, glucagon-like peptide-1, now used in the treatment of patients with type 2 diabetes and obesity, and glucagon-like peptide-2, recently approved for patients with short bowel syndrome. Dr. Brubaker has published over 200 papers and has trained more than 200 students and fellows during her career. She was supported by a Tier 1 Canada Research Chair in Vascular and Metabolic Biology from 2001-2022 and received the Diabetes Canada Lifetime Achievement Award in 2020. She was inducted as a Fellow of the Royal Society of Canada in 2016 and as a Fellow of the Canadian Academy of Health Sciences in 2023.
Dr. Pieter Cohen | "Dietary supplements: Are they what they appear to be?"
Dietary supplements list vitamins, minerals, probiotics, protein powders and a myriad of other ingredients on the label - but do they actually contain what's on the label? Will they provide their advertised health benefits? Dr. Cohen explores the key differences between dietary supplement labels and what is really found in the pills and powders within.
Dr. Pieter Cohen, a graduate of Yale School of Medicine, is an associate professor of Medicine at Harvard Medical School and an internist at Cambridge Health Alliance in Somerville, Massachusetts. He is an expert on the safety of dietary supplements. Along with analytic chemistry colleagues, he has spent the last fifteen years exploring the boundaries between drugs and supplements. Science has described him as “something of a mix of Indiana Jones and Sherlock Holmes in the supplement world. With chemist colleagues in the United States, Brazil, and Europe, he hunts for drugs illegally buried in supplements.” His advocacy has led to the US Food and Drug Administration banning multiple drugs and issuing dozens of warnings. His work has been published in the the top medical and public health journals including the New England Journal of Medicine, JAMA, JAMA Internal Medicine, American Journal of Public Health and Annals of Internal Medicine.
